B Cherie Millar Selected Research

B Cherie Millar Research Topics

12	Cystic Fibrosis (Mucoviscidosis) 09/2021 - 09/2003
6	Infections 09/2021 - 08/2004
2	Persistent Infection 09/2021 - 01/2018
1	Chronic Disease (Chronic Diseases) 07/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Meningitis 01/2017
1	Endocarditis 09/2013
1	Fever (Fevers) 05/2009
1	Bacterial Infections (Bacterial Infection) 11/2008
1	Warts (Wart) 11/2008
1	Wounds and Injuries (Trauma) 03/2005
1	Bacteremia 08/2004
1	Hematologic Neoplasms (Hematological Malignancy) 08/2004
1	Mycoses (Diseases, Fungus) 08/2004
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2002
1	Farmer's Lung 12/2002

6	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 08/2004
2	Pharmaceutical PreparationsIBA 06/2020 - 01/2020
2	Ribosomal DNA (rDNA)IBA 03/2005 - 12/2002
1	Anti-Infective Agents (Microbicides)IBA 09/2021
1	Tobramycin (Nebcin)FDA LinkGeneric 09/2021
1	AgarIBA 10/2020
1	Framycetin (Framycetin Sulfate)IBA 07/2018
1	Amikacin (A.M.K)FDA LinkGeneric 07/2018
1	apramycinIBA 07/2018
1	AminoglycosidesIBA 07/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	MenACWYIBA 01/2017
1	VaccinesIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	QuinolonesIBA 03/2011
1	Azithromycin (Zithromax)FDA LinkGeneric 09/2009
1	MacrolidesIBA 09/2009
1	antineoplaston A10 (A 10)IBA 05/2009
1	Tea Tree OilIBA 11/2008
1	Ribosomal RNAIBA 08/2004
1	28S Ribosomal RNAIBA 08/2004
1	16S Ribosomal RNAIBA 08/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2003
1	Immunoglobulin G (IgG)IBA 12/2002

3	Therapeutics 10/2020 - 09/2013
2	Nebulizers and Vaporizers (Inhaler) 09/2021 - 10/2020
1	Prostheses and Implants (Prosthesis) 05/2009